A possible way to reenergize T cells exhausted from fighting a tumor

by Bob Yirka , Medical XpressScanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIHAn international team of researchers has found a possible way to reenergize T cells exhauste

Updated on: March 26,2024

A possible way to reenergize T cells exhausted from fighting a tumor

by Bob Yirka , Medical XpressScanning electron micrograph of human T lymphocyte or T cell. Credit: NIAID/NIHAn international team of researchers has found a possible way to reenergize T cells exhauste

Updated on:March 26,2024

Improving CAR-T cell therapy for solid tumors through inhibition of conventional signaling pathway

byNational University of SingaporeGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.100917Chimeric Antigen Receptor-expressing T cell (CAR-T) therapy i

Updated on: January 07,2024

Improving CAR-T cell therapy for solid tumors through inhibition of conventional signaling pathway

byNational University of SingaporeGraphical Abstract. Credit:Cell Reports Medicine(2023). DOI: 10.1016/j.xcrm.2023.100917Chimeric Antigen Receptor-expressing T cell (CAR-T) therapy i

Updated on:January 07,2024

Study outlines opportunities to achieve Cancer Moonshot goal of reducing cancer death rates

by National Institutes of HealthTo achieve the Cancer Moonshot goal, cancer death rates must decline faster. Credit: Shiels M, et al.Cancer Discovery, 2023Researchers from the National Inst

Updated on: February 18,2024

Study outlines opportunities to achieve Cancer Moonshot goal of reducing cancer death rates

by National Institutes of HealthTo achieve the Cancer Moonshot goal, cancer death rates must decline faster. Credit: Shiels M, et al.Cancer Discovery, 2023Researchers from the National Inst

Updated on:February 18,2024

Study tests new vaccine for precancerous cervical cells

by Kelsey Herbers,Vanderbilt UniversityCredit: CC0 Public DomainVanderbilt University Medical Center is participating in an international study to determine the effectiveness of a new therapeuti

Updated on: March 01,2024

Study tests new vaccine for precancerous cervical cells

by Kelsey Herbers,Vanderbilt UniversityCredit: CC0 Public DomainVanderbilt University Medical Center is participating in an international study to determine the effectiveness of a new therapeuti

Updated on:March 01,2024

Time of day matters when it comes to cancer diagnosis and treatment, says metastasis study

byCell PressCredit: Unsplash/CC0 Public DomainYour circadian rhythm doesn't just govern your sleeping schedule; it can also impact cancer development, diagnosis, and treatment. In a review p

Updated on: January 23,2024

Time of day matters when it comes to cancer diagnosis and treatment, says metastasis study

byCell PressCredit: Unsplash/CC0 Public DomainYour circadian rhythm doesn't just govern your sleeping schedule; it can also impact cancer development, diagnosis, and treatment. In a review p

Updated on:January 23,2024

Study finds triple-negative breast cancer tumors with increased immune cells have lower risk of recurrence after surgery

by Mayo ClinicCredit: Unsplash/CC0 Public DomainA new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cel

Updated on: April 06,2024

Study finds triple-negative breast cancer tumors with increased immune cells have lower risk of recurrence after surgery

by Mayo ClinicCredit: Unsplash/CC0 Public DomainA new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cel

Updated on:April 06,2024

New cancer immunotherapy approach turns human cells into tiny anti-tumor drug factories

by University of California - San DiegoUC San Diego School of Medicine researchers developed a method to use B cells to manufacture and secrete microRNA-containing vesicles and showed they can in

Updated on: March 12,2024

New cancer immunotherapy approach turns human cells into tiny anti-tumor drug factories

by University of California - San DiegoUC San Diego School of Medicine researchers developed a method to use B cells to manufacture and secrete microRNA-containing vesicles and showed they can in

Updated on:March 12,2024

Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicDespite improvements in median and short-term survival rates for patients with glioblastoma, the most common brain tumor in adults, the percentage of

Updated on: May 27,2024

Study: More aggressive treatments needed to improve 5-year survival rate for glioblastoma

by Joe Dangor,Mayo ClinicCredit: Mayo ClinicDespite improvements in median and short-term survival rates for patients with glioblastoma, the most common brain tumor in adults, the percentage of

Updated on:May 27,2024

Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainCAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even fo

Updated on: January 25,2024

Collaborative study shows CAR-T cell therapy safe, effective even for high-risk patients

byUniversity of Miami Leonard M. Miller School of MedicineCredit: Pixabay/CC0 Public DomainCAR-T cell therapy is a safe and effective treatment for diffuse large B-cell lymphoma (DLBCL), even fo

Updated on:January 25,2024

Bacterium may decrease effectiveness of immunotherapy

by Béatrice St-Cyr-Leroux,University of MontrealAssociation between the H. pylori seropositivity status and clinical outcomes in 97 patients with advanced melanoma. A. Stacked barplot between H.

Updated on: January 10,2024

Bacterium may decrease effectiveness of immunotherapy

by Béatrice St-Cyr-Leroux,University of MontrealAssociation between the H. pylori seropositivity status and clinical outcomes in 97 patients with advanced melanoma. A. Stacked barplot between H.

Updated on:January 10,2024

Gene set identifies glioblastomas most vulnerable to promising therapeutic

by Becky Ham,Translational Genomics Research InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers from TGen, part of City of Hope, and from the University of Califo

Updated on: July 17,2024

Gene set identifies glioblastomas most vulnerable to promising therapeutic

by Becky Ham,Translational Genomics Research InstituteGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Researchers from TGen, part of City of Hope, and from the University of Califo

Updated on:July 17,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on: February 20,2024

Researchers develop 'Goldilocks drug' to treat triple-negative breast cancer

by Mikayla Mace Kelley,University of ArizonacSNX1.3 competitively inhibits binding of EGFR to SNX1.ARibbon drawing of EGFR kinase domain (PDB ID 5CNO) and SNX1 Bar domain (PDB ID 4FZ

Updated on:February 20,2024